Terms ending in 2037
Every in-force patent on Allergan, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,117,860 | Phenyl Urea Derivatives as N-Formyl Peptide Receptor Modulators In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 10,806,628 | Dual Cap System for Container-Closures to Maintain Tip Sterility During Shelf Storage In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 10,093,548 | Production of Rounded Salt Particles In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 10,300,169 | Co-Crosslinked Hyaluronic Acid-Silk Fibroin Hydrogels for Improving Tissue Graft Viability and for Soft Tissue Augmentation In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 10,744,227 | Co-Crosslinked Hyaluronic Acid-Silk Fibroin Hydrogels for Improving Tissue Graft Viability and for Soft Tissue Augmentation In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 12,599,699 | Co-Crosslinked Hyaluronic Acid-Silk Fibroin Hydrogels for Improving Tissue Graft Viability and for Soft Tissue Augmentation In force · Medium confidence | Allergan, Inc. | In force | Medium confidence | |
| US 10,369,190 | Non-Protein Clostridial Toxin Compositions In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 10,973,890 | Non-Protein Clostridial Toxin Compositions In force · High confidence | Allergan, Inc. | In force | High confidence | |
| US 12,144,847 | Non-Protein Clostridial Toxin Compositions In force · Medium confidence | Allergan, Inc. | In force | Medium confidence | |
| US 12,171,816 | Non-Protein Clostridial Toxin Compositions In force · Medium confidence | Allergan, Inc. | In force | Medium confidence | |
| 2 more term ends in 2037 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.